Medico Remedies Shows Improved Financial Performance Amidst Changing Market Sentiment
Medico Remedies, a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a notable evaluation adjustment, indicating a shift in market sentiment. The company reported a significant profit before tax increase and demonstrated strong debt servicing capabilities, while also outperforming the broader market over the past year.
Medico Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment that reflects notable shifts in its technical indicators. The stock's technical trend has transitioned from a sideways movement to a mildly bullish stance, indicating a change in market sentiment.Key financial metrics reveal that Medico Remedies has demonstrated a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 0.94 times. The company reported a significant growth in profit before tax, reaching Rs 5.41 crore, which marks a 47.41% increase. Additionally, the operating profit to net sales ratio peaked at 16.15%, showcasing operational efficiency.
Over the past year, Medico Remedies has outperformed the broader market, generating a return of 47.22%, compared to the BSE 500's 9.57%. However, it is worth noting that promoter confidence appears to be waning, as there has been a 3.04% reduction in their stake over the previous quarter.
Overall, the recent evaluation adjustment reflects a complex interplay of technical trends and financial performance indicators for Medico Remedies.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
